Chemotherapy is the main form of treatment for cancer, but it cannot cure most types of cancer. Another form of treatment is immunotherapy, which aims to stimulate cells of the body's immune system (T cells) to kill cancer cells.
Cellular senescence is a programmed response to oncogenic (tumour-causing) stress that aims to halt the expansion of cells with malignant potential.
Liver cancer is highly fatal, it has very few treatment options, and it is one of the few cancers whose incidence is rising worldwide.
Tumour heterogeneity is a driving force for disease progression and one of the major obstacles to effective treatment. Heterogeneity is driven by mutations and other processes that generate diverse cancer cell phenotypes and functions.
Proteins represent the final product of genes and are implicated in governing most cellular functions. Production of proteins from genes is referred to as gene expression. Genes are first transcribed into messenger ribonucleic acid (mRNA).
The gene p53 is a well-known tumour suppressor gene that prevents cancer formation. It is the most commonly mutated gene among individuals with a diagnosis of cancer.
In April 2016, Burkina Faso became the first African country to introduce a national policy for universal and free healthcare for pregnant women, new mothers, and children under five.
Adolescents experience a number of major neurobiological, hormonal, physical, and psychological changes, which present important risks to their health and well-being.
Nigeria has one of the highest rates of maternal mortality in the world.
Research shows that high gender inequity translates into poor health for mothers, pregnant women, and children. At the community and individual level, gender inequities and disparities can underlie dimensions of poverty among women.